Can Vaccination with Various Types of Vaccines Make Communities Safer against COVID-19?


Cite item

Full Text

About the authors

SeyedAhmad SeyedAlinaghi

Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences

Email: info@benthamscience.net

Pegah Mirzapour

Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences

Email: info@benthamscience.net

Esmaeil Mehraeen

Department of Health Information Technology, Khalkhal University of Medical Sciences

Author for correspondence.
Email: info@benthamscience.net

References

  1. Mehraeen E, Oliaei S, Alinaghi SS, et al. COVID-19 in pediatrics: a systematic review of current knowledge and practice. Infect Disord Drug Targets 2022; 22(5): 47-57.
  2. Mehraeen E, Dadras O, Afsahi AM, et al. Vaccines for COVID-19: A systematic review of feasibility and effectiveness. Infect Disord Drug Targets 2022; 22(2): e230921196758. doi: 10.2174/1871526521666210923144837 PMID: 34554905
  3. Control CfD. Prevention Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. USA: CDC 2021.
  4. Sell S. How vaccines work: immune effector mechanisms and designer vaccines. Expert Rev Vaccines 2019; 18(10): 993-1015. doi: 10.1080/14760584.2019.1674144 PMID: 31594419
  5. Dobrynin D, Polishchuk I, Portal L, Zlotver I, Sosnik A, Pokroy B. Adsorption of SARS-CoV-2 spike proteins on various functionalized surfaces correlates with the high transmissibility of Delta and Omicron variants. Mater Today Bio 2022; 14100265. doi: 10.1016/j.mtbio.2022.100265 PMID: 35465145
  6. Guo D, Duan H, Cheng Y, Wang Y, Hu J, Shi H. Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies. Molecular Biomedicine 2022; 3(1): 12. doi: 10.1186/s43556-022-00074-3 PMID: 35461370
  7. Dai Z, Liu WC, Chen XY, Wang X, Li JL, Zhang X. Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors. Front Immunol 2023; •••: 141178662. doi: 10.3389/fimmu.2023.1178662 PMID: 37275856
  8. United Nations News. COVID ‘Shot for All’ nal, but development priority. 2021.. 2021. Available from: https://news.un.org/en/story/2021/09/1100552 (Accessed on: 12 January 2022).
  9. Nagy A, Alhatlani B. An overview of current COVID-19 vaccine platforms. Comput Struct Biotechnol J 2021; 19: 2508-17. doi: 10.1016/j.csbj.2021.04.061 PMID: 33936564
  10. Depoux A, Martin S, Karafillakis E, Preet R, Wilder-Smith A, Larson H. The pandemic of social media panic travels faster than the COVID-19 outbreak. Oxford University Press 2020; p. taaa031.
  11. Machingaidze S, Wiysonge CS. Understanding COVID-19 vaccine hesitancy. Nat Med 2021; 27(8): 1338-9. doi: 10.1038/s41591-021-01459-7 PMID: 34272500
  12. Hassan MAK, Aliyu S. Delayed access to COVID-19 vaccines: a perspective on low-income countries in Africa. Int J Health Serv 2022; 52(3): 323-9. doi: 10.1177/00207314221096365 PMID: 35469499
  13. Mehrabi Nejad MM, Moosaie F, Dehghanbanadaki H, et al. Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis. Eur J Med Res 2022; 27(1): 23. doi: 10.1186/s40001-022-00648-5 PMID: 35151362 PMCID: 8840778
  14. SeyedAlinaghi S, Karimi A, Pashaei Z, et al. . Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review. Arch Acad Emerg Med 2022; 10(1): e41. doi: 10.22037/aaem.v10i1.1597 PMID: 35765616 PMCID: 920682
  15. Dadras O,. , SeyedAlinaghi S, Karimi A, et al. COVID-19 Vaccines' Protection Over Time and the Need for Booster Doses; a Systematic Review. Arch Acad Emerg Med 2022; 10(1): e53. doi: 10.22037/aaem.v10i1.1582. PMID: 36033989 PMCID: 9397599
  16. Dadras O, Mehraeen E, Karimi A, et al. Safety and Adverse Events Related to Inactivated COVID-19 Vaccines and Novavax;a Systematic Review. Arch Acad Emerg Med 2022; 10(1): e54. doi: 10.22037/aaem.v10i1.1585 PMID: 36033990 PMCID: 9397598

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers